Leadership Team

Chai Gadde has more than two decades of senior management experience within the pharmaceutical industry, with particular expertise in supply chain management and contract negotiations with manufacturers and managed care organizations.

Chai has also been at the forefront of several startup ventures in other industries, including land development, hospitality and technology, advising these companies on strategy and operations. He is currently the CEO of Biotek ReMEDys, which he founded in 2011 to provide specialty pharmacy, home infusion and specialty infusion solutions and services. His industry affiliations include the American Managed Care Pharmacy, the American Pharmaceutical Association, the Delaware Pharmacist Society, the National Home Infusion Association and several cancer care organizations. Originally from Hyderabad, India, Chai earned his undergraduate degree in pharmacy from Bangalore University, completed his graduate work at Long Island University, and holds a Master of Business Administration from the University of Delaware.

Brian Zweben has more than 20 years of experience in the healthcare field, sharing his talents and experience among diverse healthcare field entities in both executive and advisory capacities. Throughout those years, he has aggregated his experiences and skills in recognizing and improving synergies between doctors and their patients.

Brian began his healthcare career in direct patient care and has refined his knowledge of the healthcare industry, business acumen and leadership abilities while working his way up to C-Level executive positions. His expertise in specialty pharmaceuticals, medical management and business development has led him to be a strong supporter of organizations at the forefront of researching acute diseases such as Huntington’s Disease, Multiple Sclerosis and Autism – motivating him to gain a better understanding of improving patient outcomes in acute and rare diseases. His involvement with Innovative Precision Health is a natural progression in his career as it allows him to add to his core competencies while cultivating a broader understanding of Artificial Intelligence and machine learning to help derive better clinical outcomes for patients.

Brian earned his Bachelor of Science degree in Health Science with a minor in Biology at the State University of New York at Cartland (SUNY Cortland). He is presently the COO of BioTek reMEDys, a specialty pharmacy and President of Talis Healthcare, a company providing solutions for physicians and patients requiring IV drug therapies in a non-acute setting and as an alternative to home infusions.

Mark Gudesblatt, M.D, Medical Director, South Shore Neurologic Associates

For more than 15 years, Dr. Gudesblatt has been at the forefront of incorporating multi-domain digital analytics of human performance to improve clinical care outcomes and enhance decisions, and has been involved in Neuromodulation (DBS, ITB) for over 20 years. He has also served as a Primary Investigator in various clinical research trials across multiple disease states for the past 15 years. In addition to serving as a Consultant for Numerous Pharmaceutical Companies and Not for Profit Organizations, Dr. Gudesblatt has authored many articles appearing in professional literature on numerous topics and has presented novel research at many National and International Conferences.

Dr. Gudesblatt currently serves as the Medical Director of the Comprehensive MS Care Center at South Shore Neurologic Associates, P.C. and the Infusion Center. He served on the Science Advisory Board for the Spastic Paraplegia Foundation and has been a consultant for the Neurologist for Developmental Disabilities Institute.

Dr. Gudesblatt received his undergraduate degree from The Johns Hopkins University in 1976 and his medical degree from Cornell University Medical College in 1980. His postgraduate training included a Medical Internship and a Neurologic Residency at Mount Sinai Hospital in New York, where he was the Chief Resident, followed by a Clinical Research fellowship in Neuromuscular Disease. Dr. Gudesblatt is certified by the American Board of Psychiatry and Neurology in the specialty of Neurology and has been practicing medicine for 35 years. He also has additional training in Neuro-Rehabilitation and was a member of the AAN Quality Care Committee for 5 years.

Dr. Anna Tseng is a graduate of Baylor College of Medicine. She completed an Internal Medicine internship, Neurology residency and Neurophysiology fellowship at the University of Alabama at Birmingham, and has been a board certified practicing neurologist in Dallas since 1997. Over the past two decades, Dr. Tseng has been consistently listed in D Magazine’s Best Doctors in Dallas in the field of Neurology.

Dr. Tseng is President and Managing Partner of Neurology Consultants of Dallas, a private practice neurology group. During her tenure, the group has grown to 20+ providers offering a comprehensive approach to neurological care. Services include both in-patient and out-patient needs, along with neuro-imaging, rehabilitative therapy and clinical research offerings.

Dr. Tseng also serves as the Chief Medical Officer of the Genovista High Performing Network, an accountable care organization (ACO). In her role, she works to improve the delivery of care to the patients within the organization, ensuring quality while promoting cost efficiency. As a specialist working in a primary care centric ACO, Dr. Tseng strives to build better communication and continuity of care between specialists and primary care.

Allen L. Gee MD, PhD, FAAN is a board-certified Neurologist with over 20 years of private practice experience. He has been a Health Information Technology consultant for over a decade and advocates for using technology to bridge the geographic barriers to healthcare. In 2014, Dr. Gee received the Athenahealth Vision Award.

Dr. Gee is the Jackson Hole Technology Partners Healthcare Initiative Director and previously served on the Wyoming Governor’s Health Information Exchange task force. His clinical practice, Frontier NeuroHealth, is a virtual neurology practice across the state of Wyoming.
He is the Founder and the principal investigator for Wyoming Health Innovation Living Laboratory, a proof of concept ecosystem partnering with innovative technologies and changing the face of healthcare.

As a leader in Personalized Precision NeuroHealth, Dr. Gee designed and built the “Healing Space” clinic in Cody which applies the neuroscience of architecture creating space to address the foundational drivers of NeuroHealth. Dr. Gee has been instrumental in the creation of the NeuroHealth and Integrated Neurology section of the American Academy of Neurology. He is a graduate and advisor for the AAN Palatucci Advocacy Leadership Forum and currently gives talks on Leadership, Resilience and Health Information Technology. He served on the AAN Government Relations Committee for 6 years and currently serves on the AAN Medical Economics and Practice Committee and Quality Committee. He was a member of the 2018 AAN Nominations committee.

Daniel Becker, MD, is the Director and Founder of the International Neurorehabilitation Institute in Lutherville, Maryland. He is also an Assistant Professor of Neurology at the Johns Hopkins School of Medicine. Dr. Becker is a board-certified neurologist who earned his Medical Degree from Ruprecht Karls University in Heidelberg, Germany in 2001. From 2001 to 2003, he was a Research Assistant in Neuroscience investigating the role of embryonic stem cells in spinal cord injury repair at Washington University School of Medicine in St. Louis, Missouri. At Vanderbilt University Medical Center in Nashville, Tennessee, he completed his residency in Internal Medicine in 2004 and his residency in Neurology in 2007. He then completed a fellowship in Spinal Cord Injury Medicine at the Johns Hopkins School of Medicine in Baltimore, MD. A major focus of Dr. Becker’s research has been on neural repair following inflammatory central nervous system injury. He has been lead investigator in numerous clinical trials mainly focusing on multiple sclerosis. His research has been published at many national and international meetings as well as in many journals and books.